PPB - Services

Complaints, Feedback and Enquiry

Medicine Quality Alert: Class II Medicine Recall of Cloxam Dry Syrup (Ampicillin/Cloxacillin) Batch No. 00066CXS

Sphinx Pharmaceuticals Ltd has initiated an urgent voluntary recall of Cloxam Dry Syrup (Cloxacillin/Ampicillin), Batch No. 00066CXS

From: Pharmacy and Poisons Board

Date of Recall Initiation: 30th September 2025

Recall Reference Number: REC/2025/031

Recall Classification: Class II

Recall Level: Retail/Facility level

Manufacturer: Sphinx Pharmaceuticals Ltd, Kenya

Product name: Cloxam Dry Syrup

Active Pharmaceutical Ingredient: Ampicillin/Cloxacillin 125mg and 125mg/5ml

Affected counties: All

Affected Batch

Batch Number

Date of Manufacture

Date of expiry

Pack Size

00066CXS

01/2023

12/2025

100ml

Brief description of the problem

The product did not meet the specification for appearance, which requires it to be an off white powder. Instead, brown particles were observed dispersed throughout the powder and at the base of the bottle.

Action for healthcare professionals

Quarantine all remaining stock and stop further distribution, sale, issuing or use of the above batch immediately. Await contact from Sphinx Pharmaceuticals Ltd to arrange the return.

Action for patients and caregivers

No further action is required by patients as this is a Retail/hospital Pharmacy and Wholesaler/Distributor level recall. You are advised to talk to your healthcare professional if you have the above batch of Cloxam Dry Syrup. The patients should continue taking other batches of the product, other than the impacted batch, and as prescribed by the healthcare professional.

Further Information

For inquiries about consignments of the impacted batch, please contact Sphinx Pharmaceuticals Ltd at: qaoffice@sphinx.co.ke, sphinx @sphinx.co.ke,  or by Telephone at: +254 722 565 305

You are advised to promptly report any case(s) of adverse events and suspected substandard and falsified products to the nearest healthcare facility or through the following channels:

For any further enquiries and feedback on the product recall, contact the post-marketing surveillance unit at the Pharmacy and Poisons Board via email at pms@ppb.go.ke

Download document

Medicine Quality Alert: Class II Medicine Recall of Cloxam Dry Syrup (Cloxacillin/Ampicillin) Batch No. 00066CXS
PMS Feedback Form
Full Name